Association of inflammatory markers with cerebral small vessel disease in community-based population
- PMID: 35513834
- PMCID: PMC9072153
- DOI: 10.1186/s12974-022-02468-0
Association of inflammatory markers with cerebral small vessel disease in community-based population
Abstract
Background: This study investigated the relationships of neutrophil count (NC), neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII) with cerebral small vessel disease (CSVD).
Methods: A total of 3052 community-dwelling residents from the Poly-vasculaR Evaluation for Cognitive Impairment and vaScular Events (PRECISE) study were involved in this cross-sectional study. CSVD burden and imaging markers, including white matter hyperintensity (WMH), lacunes, cerebral microbleeds (CMBs) and enlarged perivascular spaces in basal ganglia (BG-EPVS), were assessed according to total CSVD burden score. The associations of NC, NLR and SII with CSVD and imaging markers were evaluated using logistic regression models. Furthermore, two-sample Mendelian randomization (MR) analysis was performed to investigate the genetically predicted effect of NC on CSVD. The prognostic performances of NC, NLR and SII for the presence of CSVD were assessed.
Results: At baseline, the mean age was 61.2 ± 6.7 years, and 53.5% of the participants were female. Higher NC was suggestively associated with increased total CSVD burden and modified total CSVD burden (Q4 vs. Q1: common odds ratio (cOR) 1.33, 95% CI 1.05-1.70; cOR 1.28, 95% CI 1.02-1.60) and marginally correlated with the presence of CSVD (OR 1.29, 95% CI 1.00-1.66). Furthermore, elevated NC was linked to a higher risk of lacune (OR 2.13, 95% CI 1.25-3.62) and moderate-to-severe BG-EPVS (OR 1.67, 95% CI 1.14-2.44). A greater NLR was related to moderate-to-severe BG-EPVS (OR 1.68, 95% CI 1.16-2.45). Individuals with a higher SII had an increased risk of modified WMH burden (OR 1.35, 95% CI 1.08-1.69) and moderate-to-severe BG-EPVS (OR 1.70, 95% CI 1.20-2.41). MR analysis showed that genetically predicted higher NC was associated with an increased risk of lacunar stroke (OR 1.20, 95% CI 1.04-1.39) and small vessel stroke (OR 1.21, 95% CI 1.06-1.38). The addition of NC to the basic model with traditional risk factors improved the predictive ability for the presence of CSVD, as validated by the net reclassification index and integrated discrimination index (all p < 0.05).
Conclusions: This community-based population study found a suggestive association between NC and CSVD, especially for BG-EPVS and lacune, and provided evidence supporting the prognostic significance of NC.
Keywords: Cerebral small vessel disease; Inflammation; Neutrophil count; Neutrophil–lymphocyte ratio; Systemic immune-inflammation index.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interest.
Figures
Similar articles
-
Impaired glymphatic system as evidenced by low diffusivity along perivascular spaces is associated with cerebral small vessel disease: a population-based study.Stroke Vasc Neurol. 2023 Oct;8(5):413-423. doi: 10.1136/svn-2022-002191. Epub 2023 Apr 12. Stroke Vasc Neurol. 2023. PMID: 37045543 Free PMC article.
-
Implication of heart rate variability on cerebral small vessel disease: A potential therapeutic target.CNS Neurosci Ther. 2023 May;29(5):1379-1391. doi: 10.1111/cns.14111. Epub 2023 Feb 14. CNS Neurosci Ther. 2023. PMID: 36786131 Free PMC article.
-
Association of Serum Cystatin C With Cerebral Small Vessel Disease in Community-Based Population.Stroke. 2022 Oct;53(10):3123-3132. doi: 10.1161/STROKEAHA.122.039277. Epub 2022 Jul 12. Stroke. 2022. PMID: 35862202
-
Cerebral small vessel disease and prognosis in intracerebral haemorrhage: A systematic review and meta-analysis of cohort studies.Eur J Neurol. 2022 Aug;29(8):2511-2525. doi: 10.1111/ene.15363. Epub 2022 May 1. Eur J Neurol. 2022. PMID: 35435301 Review.
-
The global burden of cerebral small vessel disease in low- and middle-income countries: A systematic review and meta-analysis.Int J Stroke. 2023 Jan;18(1):15-27. doi: 10.1177/17474930221137019. Epub 2022 Nov 25. Int J Stroke. 2023. PMID: 36282189 Review.
Cited by
-
Enlarged perivascular spaces are associated with white matter injury, cognition and inflammation in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.Brain Commun. 2024 Mar 8;6(2):fcae071. doi: 10.1093/braincomms/fcae071. eCollection 2024. Brain Commun. 2024. PMID: 38495305 Free PMC article.
-
The associations between peripheral inflammatory and lipid parameters, white matter hyperintensity, and cognitive function in patients with non-disabling ischemic cerebrovascular events.BMC Neurol. 2024 Mar 4;24(1):86. doi: 10.1186/s12883-024-03591-6. BMC Neurol. 2024. PMID: 38438839 Free PMC article.
-
Association of coagulation markers with the severity of white matter hyperintensities in cerebral small vessel disease.Front Neurol. 2024 Feb 7;15:1331733. doi: 10.3389/fneur.2024.1331733. eCollection 2024. Front Neurol. 2024. PMID: 38390599 Free PMC article.
-
Causal relationship between inflammatory factors and cerebral small vessel disease: Univariate, multivariate, and summary-data-based mendelian randomization analysis.Brain Behav. 2024 Feb;14(2):e3399. doi: 10.1002/brb3.3399. Brain Behav. 2024. PMID: 38340139 Free PMC article.
-
Electroencephalographic power spectrum changes in cerebral small vessel disease combined with cognitive dysfunction and its relationship with neutrophil/lymphocyte ratio and its clinical value - a pilot study.Front Neurol. 2024 Jan 12;14:1300240. doi: 10.3389/fneur.2023.1300240. eCollection 2023. Front Neurol. 2024. PMID: 38283675 Free PMC article.
References
-
- Evans LE, Taylor JL, Smith CJ, Pritchard HAT, Greenstein AS, Allan SM. Cardiovascular comorbidities, inflammation, and cerebral small vessel disease. Cardiovasc Res. 2021;117(13):2575–2588. - PubMed
MeSH terms
Substances
Grants and funding
- No.82101358/The National Natural Science Foundation of China
- No. 81825007/The National Natural Science Foundation of China
- No. 81901177/The National Natural Science Foundation of China
- 2019ZDYF18/Key Science & Technologies R&D Program of Lishui City
- CSA2017KY007/grants from AstraZeneca Investment (China) Co., Ltd
LinkOut - more resources
Full Text Sources
Medical
